Teva Pharmaceutical Industries (TEVA) Dividend Coverage Ratio (2009 - 2018)
Teva Pharmaceutical Industries' (TEVA) quarterly Dividend Coverage Ratio came in at 87.92 in Q1 2018, up 5144.68% on a YoY basis from 1.68 in Q1 2017, and up 165.94% quarter-over-quarter from 133.33 in Q4 2017.
Analysis
Teva Pharmaceutical Industries (TEVA) Dividend Coverage Ratio (2009 - 2018) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has reported Dividend Coverage Ratio for 10 consecutive years, with 87.92 the latest figure, recorded in Q1 2018.
- For the quarter ending Q1 2018, Dividend Coverage Ratio rose 5144.68% year-over-year to 87.92; the trailing twelve-month figure through Dec 2018 stood at 199.92 (down 990.01% YoY), and the FY2018 full-year result was 199.92, down 990.01% from the prior year.
- Dividend Coverage Ratio climbed to 87.92 in Q1 2018 per TEVA's latest filing, from 133.33 in the prior quarter.
- Across five years, Dividend Coverage Ratio topped out at 87.92 in Q1 2018 and bottomed at 133.33 in Q4 2017.
- Historically, Dividend Coverage Ratio has averaged 2.46 across 5 years, with a median of 1.67 in 2015.
- The sharpest annual moves came in 2017 and 2018: Dividend Coverage Ratio sank 4344.44% in 2017, then surged 5144.68% in 2018.
- Over 5 years, Dividend Coverage Ratio stood at 1.15 in 2014, then surged by 45.33% to 1.67 in 2015, then plunged by 279.38% to 3.0 in 2016, then tumbled by 4344.44% to 133.33 in 2017, then jumped by 165.94% to 87.92 in 2018.
- According to Business Quant data, Dividend Coverage Ratio over the past three periods registered 87.92, 133.33, and 4.31 for Q1 2018, Q4 2017, and Q3 2017 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.60 Bn | 38.95 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -0.85 |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 520.75 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 411.09 Mn | 369.84 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 181.39 Mn | 181.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | 87.92 |
| Dec 31, 2017 | -133.33 |
| Sep 30, 2017 | 4.31 |
| Jun 30, 2017 | -17.49 |
| Mar 31, 2017 | 1.68 |
| Dec 31, 2016 | -3.00 |
| Sep 30, 2016 | 1.02 |
| Jun 30, 2016 | 0.61 |
| Mar 31, 2016 | 1.86 |
| Dec 31, 2015 | 1.67 |
| Sep 30, 2015 | 0.36 |
| Jun 30, 2015 | 1.87 |
| Mar 31, 2015 | 1.54 |
| Dec 31, 2014 | 1.15 |
| Sep 30, 2014 | 2.95 |
| Jun 30, 2014 | 2.49 |
| Mar 31, 2014 | 2.57 |
| Dec 31, 2013 | -2.53 |
| Sep 30, 2013 | 2.70 |
| Jun 30, 2013 | -1.69 |